Table 5.
Hospital course and clinical outcomes.
| Total (n = 36) | Encephalitis (n = 26) | Meningitis (n = 4) | Acute Flaccid Paralysis (n = 6) | |
|---|---|---|---|---|
| Admission GCS | 14 (3–15) | 13 (3–15) | 15 (15–15) | 15 (7–15) |
| Admission mRS | 4 (1–5) | 4 (1–5) | 2 (2–3) | 4 (3–5) |
| Admitted to ICU # | 18 (50.0%) | 15 (41.7%) | - | 3 (50.0%) |
| ICU length of stay, days | 9.5 (1–51) | 9 (1–51) | - | 19 (8–32) |
| Intubation required * | 14 (38.9%) | 11 (42.3%) | - | 3 (50.0%) |
| Length of mechanical ventilation, days $ |
8 (6–63) | 10.5 (6–63) | - | 8 (8–8) |
| Extubated by discharge | 7 (50.0%) | 6 (54.6%) | - | 1 (33.33%) |
| EEG-recorded seizures | 1 (2.8%) | 1 (3.85%) | - | - |
| Specific treatment given for WNND | 7 (19.4%) | 3 (11.5%) | - | 4 (66.7%) |
| IVIG | 6 (16.7%) | 2 (7.7%) | - | 4 (66.7%) |
| Dexamethasone | 1 (2.8%) | 1 (3.9%) | - | - |
| Urinary retention | 8 (22.2%) | 6 (23.1%) | - | 2 (33.3%) |
| Aspiration pneumonia | 7 (19.4%) | 4 (15.4%) | 3 (50.0%) | |
| Thrombocytopenia | 14 (38.9%) | 10 (38.5%) | - | 4 (66.7%) |
| SIADH | 4 (11.1%) | 4 (15.4%) | - | - |
| In-hospital mortality | 3 (8.3%) | 3 (11.5%) | - | - |
| Length of stay, days | 13.5 (3–60) | 14 (3–60) | 4.5 (3–5) | 22.5 (7–47) |
| Discharge GCS | 15 (6–15) | 15 (6–15) | 15 (15–15) | 15 (14–15) |
| Discharge mRS | 4 (0–6) | 4 (0–6) | 1.5 (1–2) | 4 (4–5) |
| Discharged to home | 11 (30.6%) | 6 (23.1%) | 4 (100%) | 1 (16.67%) |
Continuous measures are given as median (range); # Includes admission to the ICU at study sites only, not outside hospital ICU admissions; * Includes 8 patients intubated at an outside hospital who remained intubated on admission; $ If intubated at an outside hospital, length of ventilation refers only to the admission sites, as date of intubation was not available for all outside hospital records.